acetylcysteine has been researched along with Proteinuria in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chattipakorn, N; Kobroob, A; Kumfu, S; Peerapanyasut, W; Wongmekiat, O | 1 |
| Audard, V; Fan, Q; Henique, C; Moktefi, A; Ollero, M; Ory, V; Pawlak, A; Sahali, D; Zhang, SY | 1 |
| Cai, ZY; Sheng, ZX; Yao, H | 1 |
| Ababneh, MA; Al Demour, S; Alzoubi, KH; Hijjawi, TB; Rababa’h, AM | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydłowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Cao, J; Chen, D; Liu, Z; Wang, L | 1 |
| Saklayen, MG; Vallyathan, V; Yap, J | 1 |
| Aghamohammadzadeh, N; Heydarnejad, M; Khalaj, MR; Mobasseri, M; Noshad, H; Rasi Hashemi, S; Tabrizi, A; Tayebi Khosroshahi, H | 1 |
| Baraban, OV; Borisenok, OA; Bushma, MI; Zimatkin, SM | 1 |
| Ando, R; Fukami, K; Iwatani, R; Kaida, Y; Nakayama, Y; Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Fujii, S; Igarashi, J; Kosaka, H; Zhang, L | 1 |
| Aleksandrowicz, E; Larczynski, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Appenroth, D | 1 |
| Shaikh, ZA; Vu, TT; Zaman, K | 1 |
| Harris, DC; Rangan, GK; Tay, YC; Wang, Y | 1 |
| Brakenhoff, JP; Commandeur, JN; De Kanter, FJ; Vermeulen, NP | 1 |
2 trial(s) available for acetylcysteine and Proteinuria
| Article | Year |
|---|---|
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
Topics: Acetylcysteine; Adult; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Biomarkers; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Fibrosis; Humans; Kidney Diseases; Kidney Tubules; Male; Proteinuria; Treatment Outcome | 2008 |
Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus.
Topics: Acetylcysteine; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Losartan; Male; Middle Aged; Proteinuria; Statistics, Nonparametric | 2012 |
14 other study(ies) available for acetylcysteine and Proteinuria
| Article | Year |
|---|---|
Effectiveness of N-Acetylcysteine in the Treatment of Renal Deterioration Caused by Long-Term Exposure to Bisphenol A.
Topics: Acetylcysteine; Administration, Oral; Animals; Azotemia; Benzhydryl Compounds; Disease Models, Animal; Glomerular Filtration Rate; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Oxidative Stress; Phenols; Proteinuria; Rats; Rats, Wistar; Signal Transduction | 2021 |
CMIP interacts with WT1 and targets it on the proteasome degradation pathway.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Animals; Down-Regulation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Nephrotic Syndrome; NF-kappa B; Podocytes; Proteasome Endopeptidase Complex; Protein Binding; Proteinuria; RNA Interference; RNA, Small Interfering; Transcriptional Activation; WT1 Proteins | 2021 |
NAC attenuates adriamycin-induced nephrotic syndrome in rats through regulating TLR4 signaling pathway.
Topics: Acetylcysteine; Animals; Cytokines; Doxorubicin; Male; Nephrotic Syndrome; NF-kappa B; Proteinuria; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4 | 2017 |
The Nephroprotective Effect of N-Acetyl-L-Cysteine and Atorvastatin against Imipenem induced Nephrotoxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Atorvastatin; Blood Urea Nitrogen; Creatinine; Glomerular Filtration Rate; Glycosuria; Imipenem; Kidney; Kidney Diseases; Male; Protective Agents; Proteinuria; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Urea | 2018 |
Protective effect of N-acetylcysteine on experimental chronic cadmium nephrotoxicity in immature female rats.
Topics: Acetylcysteine; Animals; Biomarkers; Body Weight; Cadmium; Enzymes; Female; Free Radical Scavengers; Kidney Cortex; Kidney Diseases; Lipid Peroxidation; Oxidative Stress; Protective Agents; Proteinuria; Rats; Rats, Sprague-Dawley; Trace Elements; Urodynamics | 2009 |
Effect of month-long treatment with oral N-acetylcysteine on the oxidative stress and proteinuria in patients with diabetic nephropathy: a pilot study.
Topics: Acetylcysteine; Aged; Antioxidants; Creatinine; Diabetic Nephropathies; Humans; Male; Middle Aged; Oxidative Stress; Pilot Projects; Proteinuria | 2010 |
[Therapeutic effect of acetylcysteine on rats with gentamicin-induced nephropathy].
Topics: Acetylcysteine; Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Creatinine; Female; Gentamicins; Kidney Diseases; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Proteinuria; Rats | 2012 |
Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome.
Topics: Acetylcysteine; Animals; Antioxidants; Arginine; Cells, Cultured; Disease Models, Animal; Doxorubicin; Epithelial Cells; Gene Expression Regulation, Enzymologic; Humans; Kidney Tubules, Proximal; Male; Nephrotic Syndrome; Oxidative Stress; Protein-Arginine N-Methyltransferases; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Serum Albumin; Time Factors | 2012 |
Effects of thiol antioxidant on reduced nicotinamide adenine dinucleotide phosphate oxidase in hypertensive Dahl salt-sensitive rats.
Topics: Acetylcholine; Acetylcysteine; Animals; Antioxidants; Blood Pressure; Dinoprost; Endothelium, Vascular; Hydrogen Peroxide; Hypertension; Kidney Glomerulus; Male; NADPH Oxidases; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride; Superoxides; Thromboxane B2; Up-Regulation | 2004 |
Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases.
Topics: Acetylcysteine; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Peptidyl-Dipeptidase A; Proteinuria; Randomized Controlled Trials as Topic | 2008 |
Ontogenic changes in the nephrotoxicity of chromate correlate with the glutathione oxidoreduction system.
Topics: Acetylcysteine; Aging; Animals; Chromates; Female; Glutaredoxins; Glutathione; Kidney; Male; Oxidation-Reduction; Oxidoreductases; Phenobarbital; Protein Disulfide Reductase (Glutathione); Proteinuria; Rats; Sodium Compounds | 1994 |
Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants.
Topics: Acetylcysteine; Alanine Transaminase; Amitrole; Animals; Anti-Inflammatory Agents; Antioxidants; Buthionine Sulfoximine; Cadmium; Cysteine; Drug Combinations; Enzyme Inhibitors; Female; Glutathione; Glycine; Glycyrrhetinic Acid; Kidney; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Malondialdehyde; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Steroids; Time Factors; Vitamin E | 1999 |
Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats.
Topics: Acetylcysteine; Animals; Cell Movement; Doxorubicin; Kidney; Kidney Cortex; Kidney Tubules; Lipid Peroxides; Macrophages; Male; Monocytes; Nephrosis; NF-kappa B; Proteinuria; Pyrrolidines; Rats; Rats, Wistar; Thiocarbamates; Time Factors | 1999 |
Nephrotoxicity of mercapturic acids of three structurally related 2,2-difluoroethylenes in the rat. Indications for different bioactivation mechanisms.
Topics: Acetylcysteine; Animals; Biotransformation; Cysteine; Dose-Response Relationship, Drug; Fluoroacetates; Glycosuria; Hydrocarbons, Fluorinated; Hydrocarbons, Halogenated; Kidney Diseases; Organ Size; Proteinuria; Pyruvates; Pyruvic Acid; Rats; Structure-Activity Relationship; Urea | 1988 |